Clinical Trial Update: An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult Patients [Phase 2]

View source ↗

Summary

GlaxoSmithKline conducted a Phase 2 trial of mepolizumab for eosinophilic esophagitis in adults; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Oesophagitis, Eosinophilic | Phase 2 | Status: COMPLETED